Trial Profile
Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Oct 2013
Price :
$35
*
At a glance
- Drugs Landiolol (Primary)
- Indications Supraventricular tachycardia
- Focus Therapeutic Use
- Sponsors Ono Pharmaceutical
- 02 Jul 2013 Primary endpoint 'Heart-rate' has been met.
- 26 Oct 2012 New trial record